The IMID Forum
The Immune-Mediated Inflammatory Disease Forum
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Episodes
Mentioned books
Dec 23, 2021 • 22min
Author Interview: Professor Kevin Winthrop (December 2021)
Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Kevin Withrop discusses his paper on the safety of filgotinib in patients with RA.
Dec 22, 2021 • 21min
Author Interview: Professor Kevin Winthrop (November 2021)
Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Kevin Withrop discusses his paper on the incidence and risk of herpes zoster in patients with RA receiving upadacitinib.
Dec 14, 2021 • 40min
Insights at ACR 2021: Basic Science / Beyond RA
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 13, 2021 • 48min
Insights at ACR 2021: PROs and JAK Treatment
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 12, 2021 • 47min
Insights at ACR 2021: Clinical Outcomes in RA
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 11, 2021 • 30min
Insights at ACR 2021: JAKs in Spondyloarthritis
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 10, 2021 • 32min
Insights at ACR 2021: COVID-19 Vaccination and Rituximab
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 9, 2021 • 39min
Insights at ACR 2021: Impact of COVID-19 on Practice
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 7, 2021 • 40min
Insights at ACR 2021: COVID Vaccinations
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 6, 2021 • 24min
Author Interview: Professor Atul Deodhar
Professor Atul Deodhar, professor of medicine at Oregon Health & Science University.
Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Atul Deodhar discusses his review on JAK-STAT signalling in spondyloarthritis and what that means for the use of JAK inhibitors for SpA treatment.
